MaxCyte, Inc.

NASDAQ:MXCT

Medical - Devices

Healthcare
$1.28 +3.98%

+$0.05 today

Market cap
$132.16M
Beta
1.67
P/E (TTM)
-3.2
EPS (TTM)
-$0.37
52W Low $0.64High $2.37

Volume 1.67M

Average 0.95M

Income Statement

Follow revenue through to earnings.

Revenue

$33.03M

FY 2025 · Annual

-14.5% YoY

Operating Income

-$45.28M

FY 2025 · Annual

Net Income

-$44.63M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue33.89M44.26M41.29M38.63M33.03M
Cost of Revenue3.65M5.1M4.74M7.1M6.22M
Gross Profit30.25M39.16M36.55M31.53M26.8M
Gross Margin89.2%88.5%88.5%81.6%81.2%
Research & Development15.41M19.51M23.82M22.23M20.82M
Selling, General & Admin31.68M44.48M57.04M56.35M47.04M
Operating Expenses48.44M66.52M84.85M82.72M72.09M
Depreciation & Amortization1.42M2.7M4.17M4.79M5.14M
EBITDA(16.61M)(20.75M)(33.75M)(36.27M)(39.49M)
EBITDA Margin-49.0%-46.9%-81.7%-93.9%-119.6%
Operating Income(18.19M)(27.36M)(48.3M)(51.2M)(45.29M)
Operating Margin-53.7%-61.8%-117.0%-132.5%-137.1%
Interest Income150.8K3.92M10.38M10.14M7.27M
Interest Expense1.04M126.9K000
Other Income / Expenses(893.6K)3.79M10.38M10.14M655K
Income Before Tax(19.08M)(23.57M)(37.92M)(41.06M)(44.63M)
Pre-Tax Margin-56.3%-53.3%-91.8%-106.3%-135.1%
Income Tax Expense00000
Net Income(19.08M)(23.57M)(37.92M)(41.06M)(44.63M)
Net Margin-56.3%-53.3%-91.8%-106.3%-135.1%
EPS (Basic)(0.22)(0.19)(0.37)(0.39)(0.42)
EPS (Diluted)(0.22)(0.19)(0.37)(0.39)(0.42)
Weighted Avg Shares90.62M101.7M103.27M104.85M106.43M
Weighted Avg Shares (Diluted)90.62M101.7M103.27M104.85M106.43M

MXCT Earnings Waterfall · TTM

NASDAQ:MXCT · Revenue to Net Income

Key Ratios

EPS$-0.37
Gross Margin81.4%
Net Margin-126.9%
P/E Ratio-4.1
P/S Ratio20.6

Analysis

$32.3M of revenue converted into -$39.1M of net income for the selected period. Gross margin is 81.4% and net margin is -126.9%, showing how much revenue survives after costs and taxes. EPS is $-0.37, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
SC 13DSC 13D filingNov 2, 2026
SC 13DSC 13D filingOct 15, 2026
8-KCurrent reportOct 14, 2026

How much revenue does MXCT generate?

MaxCyte, Inc. (MXCT) reported $33.03M of revenue in fiscal 2025.

Is MXCT profitable?

MaxCyte, Inc. (MXCT) reported -$44.63M of net income, with a net margin of -135.1%.